|
"lin zhong zhe"的相關文件
顯示項目 46-58 / 58 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2012 |
Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chiun; Lee, Kuan-Der; Hsiao, Chi-Huang; Lu, Yen-Shen; Huang, Chien-Chung; Shen, Yin-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 盧彥伸; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
The Impact of Diabetes Mellitus on Prognosis of Early Breast Cancer in Asia
|
Chen, Wei-Wu; Shao, Yu-Yun; Shau, Wen-Yi; Lin, Zhong-Zhe; Lu, Yen-Shen; Chen, Ho-Min; Kuo, Raymond N. C.; Cheng, Ann-Lii; Lai, Mei-Shu; 陳偉武; 盧彥伸; 邵幼雲; 賴美淑; 林宗哲; 鄭安理 |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Survival Following Surgery with or without Adjuvant Chemotherapy for Stage I-IIIA Non-Small Cell Lung Cancer: An East Asian Population-Based Study
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu-Yun; Yang, Yen-Yun; Kuo, Raymond Nien-Chen; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 國立臺灣大學 |
2012 |
Survival of Patients with Small Cell Lung Carcinoma in Taiwan
|
Kuo, Yu-Hsuan; Lin, Zhong-Zhe; Yang, Yen-Yun; Shao, Yu-Yun; Shau, Wen-Yi; Kuo, Raymond N. C.; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 郭年真 |
| 國立臺灣大學 |
2010 |
以Aurora 激?為標靶之肝癌分子治療探索
|
林宗哲; Lin, Zhong-Zhe |
| 國立成功大學 |
2008-10 |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng, Reury-Perng; Yang, Chih-Hsin; Chen, Yuh-Min; Chang, Gee-Chen; Lin, Meng-Chih; Hsieh, Ruey-Kuen; Chu, Nei-Min; Lai, Ruay-Sheng; Su, Wu-Chou; Tsao, Chao-Jung; Hsia, Te-Chun; Chen, Hao-Cheng; Chen, Chih-Hung; Huang, Ming-Shyan; Wang, Jui-Long; Ho, Ming-Lin; Chung, Chih-Yuan; Yu, Chong-Jen; Chang, Wen-Cheng; Kuo, Han-Pin; Yu, Chih-Teng; Lin, Zhong-Zhe; Kao, Woei-Yau |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 國立臺灣大學 |
2008-01 |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemonaive NSCLC patients receiving first-line gefitinib monotherapy
|
Yang, Chih-Hsin; Yu, Chong-Jen; Shih, Jin-Yuan; Chang, Yeun-Chung; Hu, Fu-Chang; Tsai, Meng-Chin; Chen, Kuan-Yu; Lin, Zhong-Zhe; Huang, Ching-Ju; Shun, Chia-Tung; Huang, Chin-Lun; Bean, James; Cheng, Ann-Lii; Pao, William; Yang, Pan-Chyr |
| 國立臺灣大學 |
2007 |
Validating Aurora B as a Potential Therapeutic Target for Human Hepatocellular Carcinoma
|
林宗哲; 鄭永銘; 許輝吉; 鄭安理; LIN, ZHONG-ZHE; JENG, YUNG-MING; HSU, HEY-CHI; CHENG, ANN-LII |
| 國立臺灣大學 |
2007 |
Efficacy of a Novel Histone Deacetylase Inhibitor in Murine Models of Hepatocellular Carcinoma
|
盧彥伸; 林宗哲; 陳德蓉; 鄭安理; 陳慶士; LU, YEN-SHEN; LIN, ZHONG-ZHE; CHENG, TE-JUNG; CHENG, ANN-LII; CHEN, CHING-SHIH |
| 國立臺灣大學 |
2006 |
A Phase Ii Study of Gefitinib as First Line Treatment for Good Performance Advanced or Metastatic Non-Small Cell Lung Cancer in East Asian Patients
|
楊志新; 余忠仁; 陳焜結; 林宗哲; 郭頌鑫; 鄭安理; 楊泮池; YANG, CHIH-HSIN; YU, CHONG-JEN; CHEN, KUN-CHIEH; LIN, ZHONG-ZHE; KUO, SUNG-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR |
顯示項目 46-58 / 58 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
